Overview
Haifeng Qin practices in Fengtai, China. Qin is rated as a Distinguished expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Their top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 61 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 9 articles in the study of Small Cell Lung Cancer (SCLC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerQin isDistinguished. Learn about Lung Cancer.
- Small Cell Lung Cancer (SCLC)Qin isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Age-Related Macular Degeneration (ARMD)
- Henoch-Schonlein PurpuraQin isExperienced. Learn about Henoch-Schonlein Purpura.
- Late-Onset Retinal Degeneration
- Low Sodium LevelQin isExperienced. Learn about Low Sodium Level.
- Lung AdenocarcinomaQin isExperienced. Learn about Lung Adenocarcinoma.
- Mediastinal TumorQin isExperienced. Learn about Mediastinal Tumor.